Mark J. Rosenblum
Overview
Mark J. Rosenblum received an average of $467K in total compensation, including $208K in salary, at Flex Pharma from 2019 to 2021. Mark Rosenblum also received an average of $467K at Advaxis from 2010 to 2013.
- 2021
- 2020
- 2019
- 2013
- 2012
- 2011
- 2010
Flex PharmaExecutive Vice President, Finance and Chief Financial Officer
Flex PharmaExecutive Vice President, Finance and Chief Financial Officer
Flex PharmaExecutive Vice President, Finance and Chief Financial Officer
AdvaxisChief Financial Officer
AdvaxisChief Financial Officer
AdvaxisChief Financial Officer
AdvaxisChief Financial Officer
Source: SEC filings on April 28, 2022, April 27, 2021, February 27, 2014, April 30, 2013, and July 19, 2012.
Related executives
We found 17 more executives who work or worked at Flex Pharma and Advaxis.
David Arthur
Flex Pharma
Chief Executive Officer
Kenneth Berlin
Advaxis
Chief Executive Officer
Andres Gutierrez
Advaxis
Chief Medical Officer
Igor Gitelman
Advaxis
Chief Financial Officer
Molly Henderson
Advaxis
Chief Financial Officer
Scott Jordan
Flex Pharma
Chief Business Officer
Daniel O'Connor
Advaxis
Chief Executive Officer
Sara Bonstein
Advaxis